Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) hit a new 52-week high on Monday . The stock traded as high as $75.40 and last traded at $73.42, with a volume of 31651 shares. The stock had previously closed at $72.98.
Novozymes A/S Trading Up 1.0%
The company has a market cap of $35.36 billion, a price-to-earnings ratio of 47.78, a PEG ratio of 3.87 and a beta of 0.92. The stock has a 50-day simple moving average of $65.96 and a 200 day simple moving average of $60.57.
Novozymes A/S Company Profile
(
Get Free Report)
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Featured Stories
Before you consider Novozymes A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.
While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
